Altogether, these results demonstrate that CA4, CTX-23 and CTX act as migratory inhibitors with CA4 revealing the strongest motility inhibitor on various glioma cell species (Fig. 4B,C). The gene discussed is CA4; the disease is central nervous system cancer.